Enclave Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Sell
2,623
-116
-4% -$10.6K 0.03% 125
2026
Q1
$281K Sell
2,739
-39
-1% -$4.4K 0.04% 114
2025
Q4
$348K Sell
2,778
-16
-0.6% -$2.04K 0.05% 103
2025
Q3
$374K Sell
2,794
-59
-2% -$7.75K 0.06% 89
2025
Q2
$388K Sell
2,853
-17
-0.6% -$2.24K 0.06% 83
2025
Q1
$381K Hold
2,870
0.07% 83
2024
Q4
$325K Sell
2,870
-6
-0.2% -$693 0.05% 96
2024
Q3
$328K Buy
+2,876
New +$315K 0.06% 92

Other funds holding ABT

Enclave Advisors's ABT Position: Q2 2026 in Review

Enclave Advisors reduced its Abbott (ABT) stake by 4.2% in Q2 2026, selling an estimated $10.6K and leaving 2,623 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #125.

Enclave Advisors first reported a position in ABT in Q3 2024 and has held it in 8 quarters since. The position peaked at $388K in Q2 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Enclave Advisors held 2,623 shares of Abbott worth $238K as of Q2 2026.
  • Enclave Advisors sold 116 Abbott shares in Q2 2026, an estimated $10.6K.
  • Abbott made up 0.03% of Enclave Advisors's portfolio in Q2 2026, its #125 holding.
  • Enclave Advisors first reported a position in Abbott in Q3 2024 and has held it in 8 quarters since.
  • Enclave Advisors's Abbott position peaked at $388K in Q2 2025.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Enclave Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.